These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3979438)

  • 1. TL 333, a benzhydro[g]quinoline, stimulates both D-1 and D-2 dopamine receptors: implications for the selectivity of LY 141865 towards the D-2 receptor.
    Itoh Y; Goldman ME; Kebabian JW
    Eur J Pharmacol; 1985 Jan; 108(1):99-101. PubMed ID: 3979438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor.
    Tsuruta K; Frey EA; Grewe CW; Cote TE; Eskay RL; Kebabian JW
    Nature; 1981 Jul; 292(5822):463-5. PubMed ID: 7254340
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the dopamine D-2 receptor agonist, LY 171555, on radial arm maze performance in rats.
    Levin ED; Bowman RE
    Pharmacol Biochem Behav; 1986 Nov; 25(5):1117-9. PubMed ID: 2947250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine.
    Nordmann R; Petcher TJ
    J Med Chem; 1985 Mar; 28(3):367-75. PubMed ID: 3973904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor.
    Martin JR; Beinfeld MC; Wang RY
    Brain Res; 1986 Nov; 397(2):253-8. PubMed ID: 2948613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G; Arnt J; Hyttel J
    Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic activity of cis-trans isomers of benzhydro[f]quinoline analogs.
    Verimer T; Long JP; Rusterholz DR; Flynn JR; Cannon JG; Lee T
    Eur J Pharmacol; 1980 Jun; 64(4):271-7. PubMed ID: 7389823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LY 141865 stimulates histamine-2 (H2) receptors and dopamine-2 (DA2) receptors in the anaesthetised dog.
    Armstrong JM; Duval N; Langer SZ
    Eur J Pharmacol; 1983 Jan; 87(1):165-6. PubMed ID: 6404640
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. II. Pharmacological studies with derivatives of 2-aminotetralin, benzhydro[f]quinoline, benzhydro[g]quinoline, apomorphine and clonidine suggest a pharmacological dissimilarity between peripheral presynaptic dopamine receptors and alpha-2 adrenoceptors.
    Maixner W; Flynn JR; Arnerić SP; Cannon JG; Long JP
    J Pharmacol Exp Ther; 1983 Feb; 224(2):352-8. PubMed ID: 6296357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
    Braun AR; Chase TN
    Eur J Pharmacol; 1986 Nov; 131(2-3):301-6. PubMed ID: 3493161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum.
    Stoof JC; Kebabian JW
    Brain Res; 1982 Nov; 250(2):263-70. PubMed ID: 6293642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunostimulating effect of D2 dopamine receptor agonist quinpirole].
    Cheĭdo MA; Al'perina EL
    Biull Eksp Biol Med; 1990 Apr; 109(4):374-6. PubMed ID: 1974818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonists.
    Braun AR; Chase TN
    Eur J Pharmacol; 1988 Mar; 147(3):441-51. PubMed ID: 3259931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BHT-920 and LY-171555 (quinpirole) have similar affinities for striatal D-2 dopamine receptors, and similar affinities for striatal D-1 dopamine receptors.
    Ferré S; Guix T; Sallés J; Cuffí L; Badia A; Casas M
    Eur J Pharmacol; 1989 Jul; 166(2):303-5. PubMed ID: 2571510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
    Rosengarten H; Schweitzer JW; Egawa M; Friedhoff AJ
    Adv Exp Med Biol; 1988; 235():159-67. PubMed ID: 2976249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.